Associate Professor Viktoria Eleftheriadou discusses the launch of the UK’s first vitiligo registry as part of the VIRTUAL-UK pilot study.

Professor Thomas F. Lüscher discusses the new ESC clinical consensus statement on vaccination and its pivotal role in ...

A new analysis highlights differential long-term drug survival of commonly used biologics in psoriasis to guide treatment ...

Obstructive sleep apnoea symptoms may worsen for patients who live in areas with higher levels of air pollution, a new study ...

Patients who regularly consume a healthy diet may benefit from air pollution having less impact on their lung function, a ...

Patients with psoriasis are at increased risk of developing age-related macular degeneration, new research has found.

Moving medical supplies via drone was once a farfetched idea, but there are now multiple projects working to make it a reality. Kathy Oxtoby considers five case studies from the UK and the Netherlands ...

A personalised exercise and self-management rehabilitation programme for adults living with multimorbidity is both acceptable and deliverable, according to a feasibility study, paving the way for ...

Patients with syncope typically present with a transient loss of consciousness, which can have a broad spectrum of causes. Here, Professor Martin Möckel, of the EUSEM syncope group, summarises how ...

Serum immunoglobulin A (IgA) is a reliable biomarker of prior respiratory syncytial virus (RSV) infection in children under two years of age, a multinational study has confirmed. Human RSV is a highly ...

Artificial intelligence (AI)-enabled electrocardiography (ECG) can accurately predict an individual patient’s risk of future cardiovascular events as well as their short and long-term risk of dying, a ...

Depemokimab (brand name Exdensur) has been approved by the Medicines and Healthcare products Regulatory Agency (MHRA) and is the first and only ultra-long-acting biologic with twice-yearly dosing to ...